|
|
||||||||
Department of Medicine, University of Vermont, Burlington, Vermont
Submitted 17 September 2004 ; accepted in final form 18 November 2004
Chronic heart failure is characterized by changes in skeletal muscle that contribute to physical disability. Most studies to date have investigated defects in skeletal muscle oxidative capacity. In contrast, less is known about how heart failure affects myofibrillar protein metabolism. Thus we examined the effect of heart failure on skeletal muscle myofibrillar protein metabolism, with a specific emphasis on changes in myosin heavy chain (MHC) protein content, synthesis, and isoform distribution in 10 patients with heart failure (63 ± 3 yr) and 11 controls (70 ± 3 yr). In addition, we examined the relationship of MHC protein metabolism to inflammatory markers and physical function. Although MHC and actin protein content did not differ between groups, MHC protein content decreased with increasing disease severity in heart failure patients (r = 0.748, P < 0.02), whereas actin protein content was not related to disease severity. No difference in MHC protein synthesis was found between groups, and MHC protein synthesis rates were not related to disease severity. There were, however, relationships between C-reactive protein and both MHC protein synthesis (r = 0.442, P = 0.05) and the ratio of MHC to mixed muscle protein synthesis (r = 0.493, P < 0.03). Heart failure patients showed reduced relative amounts of MHC I (P < 0.05) and a trend toward increased MHC IIx (P = 0.06). In regression analyses, decreased MHC protein content was related to decreased exercise capacity and muscle strength in heart failure patients. Our results demonstrate that heart failure affects both the quantity and isoform distribution of skeletal muscle MHC protein. The fact that MHC protein content was related to both exercise capacity and muscle strength further suggests that quantitative alterations in MHC protein may have functional significance.
sarcopenia; cardiac cachexia; myosin heavy chain isoform; cytokine; actin
This article has been cited by other articles:
![]() |
Y. Okada, M. J. Toth, and P. VanBuren Skeletal muscle contractile protein function is preserved in human heart failure J Appl Physiol, April 1, 2008; 104(4): 952 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. W. Petersen, F. Magkos, P. Atherton, A. Selby, K. Smith, M. J. Rennie, B. K. Pedersen, and B. Mittendorfer Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E843 - E848. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Liguzinski and B. Korzeniewski Oxygen delivery by blood determines the maximal VO2 and work rate during whole body exercise in humans: in silico studies Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H343 - H353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Toth, P. A. Ades, M. M. LeWinter, R. P. Tracy, and A. Tchernof Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones J Appl Physiol, January 1, 2006; 100(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Szentesi, M. A. Bekedam, B. J. van Beek-Harmsen, W. J. van der Laarse, R. Zaremba, A. Boonstra, F. C. Visser, and G. J. M. Stienen Depression of force production and ATPase activity in different types of human skeletal muscle fibers from patients with chronic heart failure J Appl Physiol, December 1, 2005; 99(6): 2189 - 2195. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |